RESULTS OF TREATMENT OF MALIGNANT GERM-CELL TUMORS IN 93 CHILDREN - A REPORT FROM THE CHILDRENS-CANCER-STUDY-GROUP

被引:63
作者
ABLIN, AR
KRAILO, MD
RAMSAY, NKC
MALOGOLOWKIN, MH
ISAACS, H
RANEY, RB
ADKINS, J
HAYS, DM
BENJAMIN, DR
GROSFELD, JL
LEIKIN, SL
DEUTSCH, M
HAMMOND, GD
机构
[1] CHILDRENS HOSP LOS ANGELES,LOS ANGELES,CA
[2] MD ANDERSON CANC CTR,HOUSTON,TX
[3] CHILDRENS HOSP & MED CTR,SEATTLE,WA
[4] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
[5] UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90033
[6] UNIV MINNESOTA,MED CTR,MINNEAPOLIS,MN 55455
[7] INDIANA UNIV,JAMES WHITCOMB RILEY HOSP CHILDREN,MED CTR,INDIANAPOLIS,IN 46223
[8] CHILDRENS HOSP,NATL MED CTR,WASHINGTON,DC 20010
[9] CHILDRENS HOSP PITTSBURGH,PITTSBURGH,PA
[10] PITTSBURGH PRESBYTERIAN HOSP,PITTSBURGH,PA
关键词
D O I
10.1200/JCO.1991.9.10.1782
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report treatment results in 93 children entered on study from 1978 to 1984 with malignant germ cell tumors (MGCTs), excluding dysgerminoma and tumors of the testis or brain. The estimated 4-year survival and event-free survival (EFS) for all 93 patients were 54% and 49%, respectively. For 30 children with ovarian tumors, the estimated 4-year survival was 67% and EFS was 63%. For 63 children with nongonadal tumors, survival and EFS were 48% and 42%, respectively. The comparison of EFS between ovarian and nongonadal tumors was significant at P = .03. The treatment plan included a second-look surgical procedure after 18 weeks of chemotherapy. Over half of 36 patients evaluated as having a residual mass present immediately before second-look surgery had no malignant tumor after review of surgical specimens. Age greater than 11 years at diagnosis, incomplete removal of tumor at first surgery, and more than one structure or organ involved at diagnosis increased the risk for adverse event. The histologic subtype of the primary tumor was not related to outcome. Diagnosis was verified by independent pathologic review, and treatment was uniform. Seventeen percent of all registered patients (21 of 127) were excluded because of ineligible pathologic diagnoses; sixty percent (13 of 21) were immature teratomas.
引用
收藏
页码:1782 / 1792
页数:11
相关论文
共 34 条
[1]   OVARIAN NEOPLASMS IN CHILDHOOD AND ADOLESCENCE .I. TUMORS OF GERM CELL ORIGIN [J].
ABELL, MR ;
JOHNSON, VJ ;
HOLTZ, F .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1965, 92 (08) :1059-&
[2]  
BRODEUR G, 1982, CANCER, V48, P2608
[3]   MALIGNANT OVARIAN TUMORS IN CHILDREN [J].
EIN, SH .
JOURNAL OF PEDIATRIC SURGERY, 1973, 8 (04) :539-542
[4]   CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].
EINHORN, LH ;
DONOHUE, J .
ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298
[5]   2 DECADES OF EXPERIENCE WITH TESTICULAR-TUMORS IN CHILDREN AT ST-JUDE-CHILDRENS-RESEARCH-HOSPITAL [J].
FERNANDES, ET ;
ETCUBANAS, E ;
RAO, BN ;
KUMAR, APM ;
THOMPSON, EI ;
JENKINS, JJ .
JOURNAL OF PEDIATRIC SURGERY, 1989, 24 (07) :677-682
[6]  
FLAMANT F, 1984, CANCER, V54, P1687, DOI 10.1002/1097-0142(19841015)54:8<1687::AID-CNCR2820540833>3.0.CO
[7]  
2-U
[8]   NON-TESTICULAR GERM-CELL TUMORS - ANALYSIS OF THE MAKEI-83 MAKEI-86 THERAPY STUDY AND PROTOCOL CHANGES FOR THE FOLLOW-UP-STUDY [J].
GOBEL, U ;
BAMBERG, M ;
HAAS, RJ ;
BOKKERINK, JPM ;
BRAMSWIG, G ;
CALAMINUS, G ;
ENGERT, J ;
GADNER, H ;
HAVERS, W ;
JANKASCHAUB, GE ;
JURGENS, H ;
VONMATTHIESEN, H ;
NIETHAMMER, D ;
SAUER, D ;
SPAAR, HJ ;
STERNSCHULTE, W ;
WEISSBACH, L ;
HARMS, D .
KLINISCHE PADIATRIE, 1989, 201 (04) :247-260
[9]   INTRACRANIAL GERM-CELL TUMORS - ANALYSIS OF THE MAKEI-83 MAKEI-86 THERAPY STUDY AND PROTOCOL CHANGES FOR THE FOLLOW-UP-STUDY [J].
GOBEL, U ;
BAMBERG, M ;
BUDACH, V ;
HAAS, RJ ;
JANKASCHAUB, G ;
KUHL, J ;
LENARD, HG ;
RISTER, M ;
SPAAR, HJ .
KLINISCHE PADIATRIE, 1989, 201 (04) :261-268
[10]  
GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727